Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

ResMed Inc. (RMD)

218.99   3.04 (1.41%) 03-31 16:00
Open: 217.23 Pre. Close: 215.95
High: 219.52 Low: 217.17
Volume: 471,659 Market Cap: 32,172(M)

Technical analysis

as of: 2023-03-31 4:21:45 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 257.74     One year: 301.04
Support: Support1: 210.5    Support2: 204.22
Resistance: Resistance1: 220.66    Resistance2: 257.74
Pivot: 211.8
Moving Average: MA(5): 215.46     MA(20): 212.19
MA(100): 217.72     MA(250): 218.78
MACD: MACD(12,26): 0.1     Signal(9): -1
Stochastic oscillator: %K(14,3): 86.2     %D(3): 78.2
RSI: RSI(14): 58.4
52-week: High: 253.66  Low: 189.39
Average Vol(K): 3-Month: 627 (K)  10-Days: 431 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ RMD ] has closed Bollinger Bands are 33.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 219.78 - 220.63 220.63 - 221.47
Low: 214.91 - 215.94 215.94 - 216.97
Close: 217.32 - 218.89 218.89 - 220.45

Company Description

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Headline News

Fri, 31 Mar 2023
ResMed Inc. stock rises Friday, still underperforms market - MarketWatch

Fri, 31 Mar 2023
ResMed Inc. (NYSE:RMD) Given Average Rating of "Moderate Buy ... - MarketBeat

Thu, 30 Mar 2023
2023-03-30 | NYSE:RMD | Press Release | ResMed Inc. - Stockhouse

Fri, 24 Mar 2023
Congress Asset Management Co. MA Lowers Stake in ResMed Inc ... - MarketBeat

Wed, 22 Mar 2023
LVZ Inc. Takes $334000 Position in ResMed Inc. (NYSE:RMD) - MarketBeat

Thu, 16 Mar 2023
Reasons Why You Should Retain ResMed (RMD) Stock For Now - Nasdaq

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Medical Instruments & Supplies
Shares Out. 147 (M)
Shares Float 146 (M)
% Held by Insiders 1.2 (%)
% Held by Institutions 66.4 (%)
Shares Short 1,080 (K)
Shares Short P.Month 845 (K)

Stock Financials

EPS 5.46
EPS Est Next Qtl 0.75
EPS Est This Year 3.05
EPS Est Next Year 3.4
Book Value (p.s.) 25.45
Profit Margin (%) 21.5
Operating Margin (%) 28
Return on Assets (ttm) 11.5
Return on Equity (ttm) 23.5
Qtrly Rev. Growth 15.5
Gross Profit (p.s.) 14.02
Sales Per Share 25.59
EBITDA (p.s.) 8.03
Qtrly Earnings Growth 11.6
Operating Cash Flow 370 (M)
Levered Free Cash Flow 124 (M)

Stock Valuations

PE Ratio 40.03
PEG Ratio 3.2
Price to Book value 8.6
Price to Sales 8.55
Price to Cash Flow 86.89

Stock Dividends

Dividend 0.43
Forward Dividend 0
Dividend Yield 0.2%
Dividend Pay Date 2021-12-15
Ex-Dividend Date 2021-11-08
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.